Salzmann Peter
SEC CIK 1796309 · EDGAR
BoughtSold
Most active insiders at IMVT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Roivant Sciences Ltd. | Dir, 10% | $350.00M | — |
| 2 | Fromkin Andrew J. | Dir | — | $7.96M |
| 3 | Stout Jay S | CTO | — | $2.27M |
| 4 | Gloria Melanie | COO | — | $1.60M |
| 5 | Girao Tiago | CFO | — | $1.41M |
| 6 | Van Tuyl Christopher | CLO | — | $1.31M |
| 7 | Venker Eric | CEO, Dir | — | $461.8K |
| 8 | Pande Atul | Dir | — | $424.6K |
| 9 | Hughes Douglas J. | Dir | — | $348.7K |
| 10 | Geffner Michael | Chief Medical Off | — | $70.1K |
Salzmann Peter made no open-market trades at IMVT in the last 12 months.
Transactions 39
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-17 | 2025-04-16 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $14.89 | -8,321 | 1.18M | -0.7% | -$123.9K | |
| 2025-04-11 | 2025-04-09 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $12.99 | -28.1K | 1.19M | -2% | -$364.9K | |
| D | 2025-04-03 | 2025-04-01 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | A - Grant | $0.00 | +265.8K | 1.21M | +28% | $0 |
| 2025-02-21 | 2025-02-19 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $20.86 | -15.4K | 948.8K | -2% | -$322.1K | |
| M | 2025-01-17 | 2025-01-15 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $23.83 | -8,767 | 964.6K | -0.9% | -$208.9K |
| 2025-01-10 | 2025-01-08 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $24.10 | -5,105 | 973.0K | -0.5% | -$123.0K | |
| 2024-11-22 | 2024-11-20 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $25.45 | -16.7K | 978.1K | -2% | -$424.8K | |
| 2024-10-18 | 2024-10-16 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $28.79 | -9,095 | 994.8K | -0.9% | -$261.8K | |
| 2024-10-11 | 2024-10-09 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $29.56 | -4,460 | 1.00M | -0.4% | -$131.8K | |
| M | 2024-08-23 | 2024-08-21 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $31.86 | -15.1K | 1.01M | -1% | -$480.1K |
| M | 2024-07-19 | 2024-07-17 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $29.69 | -8,685 | 1.02M | -0.8% | -$257.9K |
| 2024-07-10 | 2024-07-09 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $28.06 | -4,619 | 1.03M | -0.4% | -$129.6K | |
| 2024-06-03 | 2024-05-30 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Salzmann Peter | Dir | A - Grant | $0.00 | +2,783 | 2,783 | New | $0 | |
| 2024-05-24 | 2024-05-22 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $29.65 | -16.2K | 1.04M | -2% | -$479.2K | |
| M | 2024-04-19 | 2024-04-17 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $29.06 | -34.1K | 1.06M | -3% | -$990.3K |
| 2024-04-10 | 2024-04-09 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $31.18 | -4,807 | 1.09M | -0.4% | -$149.9K | |
| D | 2024-04-04 | 2024-04-02 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | A - Grant | $0.00 | +160.5K | 1.09M | +17% | $0 |
| 2024-02-23 | 2024-02-22 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $36.15 | -13.5K | 931.2K | -1% | -$486.4K | |
| 2024-01-09 | 2024-01-05 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $38.59 | -3,824 | 944.7K | -0.4% | -$147.6K | |
| M | 2023-11-24 | 2023-11-22 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $32.78 | -16.2K | 948.5K | -2% | -$531.6K |
| M | 2023-10-06 | 2023-10-05 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $36.24 | -5,239 | 969.1K | -0.5% | -$189.9K |
| M | 2023-09-01 | 2023-08-30 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $22.02 | -56.8K | 975.9K | -5% | -$1.25M |
| M | 2023-08-16 | 2023-08-14 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $21.42 | -103.1K | 1.03M | -9% | -$2.21M |
| 2023-08-08 | 2023-08-07 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $21.73 | -101.3K | 1.13M | -8% | -$2.20M | |
| 2023-07-13 | 2023-07-12 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $19.73 | -3,233 | 1.23M | -0.3% | -$63.8K | |
| 2023-04-19 | 2023-04-18 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $15.27 | -3,395 | 1.23M | -0.3% | -$51.8K | |
| D | 2023-04-14 | 2023-04-12 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | A - Grant | $0.00 | +243.8K | 1.24M | +25% | $0 |
| 2023-01-13 | 2023-01-11 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $16.80 | -4,021 | 993.9K | -0.4% | -$67.6K | |
| 2022-10-17 | 2022-10-13 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $9.18 | -2,793 | 998.0K | -0.3% | -$25.6K | |
| 2022-09-29 | 2022-09-28 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $4.67 | -1,605 | 1.00M | -0.2% | -$7,495 | |
| 2022-09-01 | 2022-08-30 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $5.83 | -1,644 | 1.00M | -0.2% | -$9,585 | |
| D | 2022-08-19 | 2022-08-17 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | A - Grant | $0.00 | +451.3K | 1.00M | +82% | $0 |
| 2022-07-29 | 2022-07-27 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $4.27 | -1,528 | 552.7K | -0.3% | -$6,525 | |
| 2022-07-01 | 2022-06-29 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $4.02 | -1,376 | 554.3K | -0.2% | -$5,532 | |
| 2022-05-25 | 2022-05-24 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $3.79 | -1,471 | 555.6K | -0.3% | -$5,575 | |
| 2022-04-29 | 2022-04-27 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $4.72 | -1,622 | 557.1K | -0.3% | -$7,656 | |
| 2022-04-14 | 2022-03-24 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $5.90 | -19.2K | 558.7K | -3% | -$113.4K | |
| 2022-01-11 | 2022-01-07 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | S - Sale | $7.25 | -125.2K | 578.0K | -18% | -$907.4K | |
| 2021-08-04 | 2021-08-03 | IMVT | Immunovant, Inc. | Salzmann Peter | CEO, Dir | A - Grant | $0.00 | +570.6K | 703.1K | +431% | $0 |
Purchase Sale Sale after option exercise All abbreviations